Chemical Structure (Asmanex Hfa 01)
Asmanex Hfa Aerosol
Product Images NDC 78206-111
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Asmanex Hfa (NDC 78206-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Asmanex Hfa 02)
Figure 2 (Asmanex Hfa 03)
This appears to be a list of three separate items: "Upright Position", "Blue Mouthpiece", and "/ /ink Cap". Without additional context, it is not clear what these items refer to or what their purpose is.*
Figure 3 (Asmanex Hfa 04)
Figure 4 (Asmanex Hfa 05)
This text indicates that a medication or substance is intended for inhalation through the mouth. It is important to follow the instructions and use only as directed by a healthcare professional.*
Figure 5 (Asmanex Hfa 06)
Figure 6 (Asmanex Hfa 07)
Principal Display Panel (100 mcg Canister Carton)
Asmanex HFA is an inhalation aerosol used for oral inhalation only. It contains mometasone furoate in propellant with additional ingredients like ethanol and oleic acid. The canister has 120 metered actuations and weighs 13g. The medicine should be stored at a controlled temperature and should not be punctured or stored near heat or open flames. It is important to shake the canister well before use and to keep it out of the reach of children. The usual dosage can be found in the package insert. This medicine is manufactured by Kindeva Drug Delivery Limited in Loughborough, UK and is a subsidiary of Organon LLC.*
Principal Display Panel (200 mcg Canister Carton)
This text describes the use and storage guidelines for Asmanex HFA Inhalation Aerosol containing mometasone furoate as the active ingredient. It is recommended to use the canister only with the Asmanex HFA actuator and to shake well before use. The tamper-evident seal ensures the integrity of the product, and the lot number and expiration date are printed on the package. The canister should be stored at a controlled room temperature, within the range of 20-25°C (68.77°F) and can be kept at excursions of 15-30°C (59-86°F) as permitted by USP Control Room Temperature. The package also includes warnings to avoid contact with eyes, keep away from children and fire, and refrain from puncturing or exposing the contents to high temperatures. The text also highlights the manufacturer's details and copyright information.*
Principal Display Panel (50 mcg Canister Carton)
Asmanex HFA is an inhalation aerosol medication containing mometasone furoate. It is recommended to shake the canister before use and store it at room temperature. The medication should not be sprayed in eyes and should be kept away from children. The usual dosage must be followed, and the patient should refer to the package insert for information. The canister should only be used with the Asmanex HFA actuator, and caution should be taken not to puncture the container or use it near heat or open flames. The medication should not be exposed to temperatures above 120°F. The canister has a net weight of 13g and contains 120 metered actuations. The text contains lot and expiry area legends printed online, and space reserved for serialization with a 2D barcode, GTIN, and serial number.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
